Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1997-8-12
|
pubmed:abstractText |
Gram-positive bacteria, notably coagulase negative staphylococci, have become an important cause of infection in neonates. Furthermore, many of these pathogens are now resistant to multiple antibacterial agents. Teicoplanin, a glycopeptide antibiotic, is active against a broad range of Gram-positive pathogens, including methicillin-resistant staphylococci. It has advantages over vancomycin in terms of tolerability, with a lower propensity to cause nephrotoxicity and anaphylactoid-like reactions, and in terms of ease of administration and monitoring requirements. The clinical utility of teicoplanin in neonates with Gram-positive infections has been investigated in several noncomparative studies. Clinical and bacteriological response rates in 173 neonates treated with teicoplanin 8-10 mg/kg intravenously or intramuscularly once daily after a loading-dose regimen of 10-20 mg/kg per day have ranged from 80%-100% and 83%-100%, respectively. Few adverse events related to teicoplanin have been reported in this patient population. CONCLUSION: Teicoplanin (8-10 mg/kg) administered intravenously or intramuscularly once daily after a loading-dose regimen of 15-20 mg/kg per day appears to be an effective and well tolerated treatment for Gram-positive infections in neonates.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0340-6199
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
156
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
423-7
|
pubmed:dateRevised |
2005-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9208233-Anti-Bacterial Agents,
pubmed-meshheading:9208233-Gram-Positive Bacterial Infections,
pubmed-meshheading:9208233-Humans,
pubmed-meshheading:9208233-Infant, Newborn,
pubmed-meshheading:9208233-Infant, Newborn, Diseases,
pubmed-meshheading:9208233-Methicillin Resistance,
pubmed-meshheading:9208233-Sepsis,
pubmed-meshheading:9208233-Teicoplanin
|
pubmed:year |
1997
|
pubmed:articleTitle |
A review of teicoplanin in the treatment of serious neonatal infections.
|
pubmed:affiliation |
Dept of Paediatrics, Policlinico Hospital, University of Verona, Italy.
|
pubmed:publicationType |
Journal Article,
Review
|